Breaking News, Collaborations & Alliances

Medivir, Ferrer in Nordic Pact

Extends marketing for Adasuve

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Medivir AB and Ferrer have entered a license and distribution agreement for the commercialization of Adasuve in the Nordic region. In Europe, Adasuve is approved for the treatment of mild to moderate agitation of patients with schizophrenia or bipolar disease. Ferrer grants to Medivir the exclusive rights to promote, market, sell and distribute Adasuve in the Nordic region, covering Denmark, Finland, Norway, Iceland and Sweden. Adasuve is a hand-held inhaler designed to deliver the drug to the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters